Human Biotransformation of the Nonnucleoside Reverse Transcriptase Inhibitor Rilpivirine and a Cross-Species Metabolism Comparison

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.01401-13
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Minority Variants Associated With Transmitted and Acquired HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor Resistance: Implications for the Use of Second-Generation Nonnucleoside Reverse Transcriptase Inhibitors

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2009English

Inhibition of Human Immunodeficiency Virus Type 1 Infection by the Candidate Microbicide Dapivirine, a Nonnucleoside Reverse Transcriptase Inhibitor

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2008English

Selection of Nonnucleoside Reverse Transcriptase Inhibitor-Associated Mutations in HIV-1 Subtype C: Evidence of Etravirine Cross-Resistance

AIDS
Infectious DiseasesAllergyImmunology
2011English

Novel Mutations L228I and Y232H Cause Nonnucleoside Reverse Transcriptase Inhibitor Resistance in Combinational Pattern

AIDS Research and Human Retroviruses
VirologyInfectious DiseasesImmunology
2016English

In Vitro Microbicidal Activity of the Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI) UC781 Against NNRTI-Resistant Human Immunodeficiency Virus Type 1

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2006English

Human Immunodeficiency Virus Type 1 Resistance or Cross-Resistance to Nonnucleoside Reverse Transcriptase Inhibitors Currently Under Development as Microbicides

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2011English

Rational Dose Selection for a Nonnucleoside Reverse Transcriptase Inhibitor Through Use of Population Pharmacokinetic Modeling and Monte Carlo Simulation

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2002English

Human Immunodeficiency Virus Reverse Transcriptase Substrate-Induced Conformational Changes and the Mechanism of Inhibition by Nonnucleoside Inhibitors.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1995English

In Vitro Evaluation of Nonnucleoside Reverse Transcriptase Inhibitors UC-781 and TMC120-R147681 as Human Immunodeficiency Virus Microbicides

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy